This experiment aims to demonstrate that insulin-dependent diabetic astronauts can be supported for short duration stays in microgravity. This will be achieved by demonstrating accurate blood glucose testing, data transmission, and insulin viability on ISS. This research will help enable people with diabetes to participate in future space missions, thus expanding the eligibility of crew and expanding access to space to more people. This project is a partnership with Burjeel Holdings PLC, a UAE-based healthcare services provider.